• Poster

Cost-effectiveness of 2+1 Dosing of 13-Valent Pneumococcal Conjugate VaccineCompared With 2+1 Dosing of 10-Valent Conjugate Vaccine in Preventing Pneumococcal Disease in Canada

Citation

Earnshaw, S. R., McDade, C. L., Zanotti, G., Farkouh, R., & Strutton, D. (2011, November). Cost-effectiveness of 2+1 Dosing of 13-Valent Pneumococcal Conjugate Vaccine Compared With 2+1 Dosing of 10-Valent Conjugate Vaccine in Preventing Pneumococcal Disease in Canada. Presented at ISPOR 14th Annual European Congress, .

Abstract